{"id":354005,"date":"2025-08-28T10:34:42","date_gmt":"2025-08-28T10:34:42","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-halozyme-therapeutics\/"},"modified":"2025-08-28T10:34:42","modified_gmt":"2025-08-28T10:34:42","slug":"how-to-buy-halozyme-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/","title":{"rendered":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354005","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Halozyme Therapeutics, Inc. (HALO) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve g\u00fc\u00e7l\u00fc 2025 performans\u0131na sahip bu yenilik\u00e7i biyoteknoloji \u015firketinde yat\u0131r\u0131m f\u0131rsatlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Halozyme Therapeutics, Inc. (HALO) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve g\u00fc\u00e7l\u00fc 2025 performans\u0131na sahip bu yenilik\u00e7i biyoteknoloji \u015firketinde yat\u0131r\u0131m f\u0131rsatlar\u0131n\u0131 ke\u015ffedin."},"intro":"\u0130la\u00e7 teslimat\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Halozyme Therapeutics (HALO), etkileyici b\u00fcy\u00fcme sa\u011flayan g\u00fc\u00e7l\u00fc bir telif hakk\u0131 i\u015f modeli ile en son bilimi birle\u015ftiriyor. ENHANZE teknolojileriyle hastalar\u0131n hayat kurtaran ila\u00e7lar\u0131 alma \u015fekli d\u00f6n\u00fc\u015f\u00fcrken, bu hisse senedi sa\u011fl\u0131k inovasyonuna kat\u0131lmak ve yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc b\u00fcy\u00fctme potansiyeli sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130la\u00e7 teslimat\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Halozyme Therapeutics (HALO), etkileyici b\u00fcy\u00fcme sa\u011flayan g\u00fc\u00e7l\u00fc bir telif hakk\u0131 i\u015f modeli ile en son bilimi birle\u015ftiriyor. ENHANZE teknolojileriyle hastalar\u0131n hayat kurtaran ila\u00e7lar\u0131 alma \u015fekli d\u00f6n\u00fc\u015f\u00fcrken, bu hisse senedi sa\u011fl\u0131k inovasyonuna kat\u0131lmak ve yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc b\u00fcy\u00fctme potansiyeli sunuyor."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve \u00d6nemli Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, Halozyme Therapeutics (HALO) NASDAQ borsas\u0131nda <strong>73,18 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi, 2025 boyunca ola\u011fan\u00fcst\u00fc bir g\u00fc\u00e7 g\u00f6stererek t\u00fcm zamanlar\u0131n en y\u00fcksek kapan\u0131\u015f fiyat\u0131na ula\u015ft\u0131<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/HALO\/halozyme-therapeutics\/stock-price-history\">Macrotrends<\/a>.<\/p> <p><strong>Takviminize not edin: 30 Ekim 2025<\/strong>, HALO yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kesinlikle kritik bir tarih. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, Halozyme'\u0131n kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 HALO Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Son tarihleri inceledi\u011fimizde kazan\u00e7lar etraf\u0131nda belirgin bir volatilite paterni g\u00f6r\u00fcl\u00fcyor:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>5 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7 A\u015f\u0131m\u0131<\/td><td>68,50 $<\/td><td><strong>%6,8 Art\u0131\u015f<\/strong> (1 hafta)<\/td><\/tr> <tr><td>6 May 2025<\/td><td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>62,30 $<\/td><td><strong>%12,7 Art\u0131\u015f<\/strong> (g\u00fc\u00e7l\u00fc rehberlik)<\/td><\/tr> <tr><td>25 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Rapor<\/td><td>58,90 $<\/td><td><strong>%5,2 Art\u0131\u015f<\/strong> (rekor gelir)<\/td><\/tr> <tr><td>5 Kas 2024<\/td><td>Ortakl\u0131k Haberi<\/td><td>54,20 $<\/td><td><strong>%7,1 Art\u0131\u015f<\/strong> (yeni i\u015f birli\u011fi)<\/td><\/tr> <tr><td>8 A\u011fu 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>51,80 $<\/td><td><strong>%3,5 Azal\u0131\u015f<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td><\/tr> <tr><td>9 May 2024<\/td><td>FDA Onay\u0131<\/td><td>48,60 $<\/td><td><strong>%9,8 Art\u0131\u015f<\/strong> (d\u00fczenleyici zafer)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri ve rehberlik art\u0131\u015flar\u0131 genellikle HALO'yu birka\u00e7 g\u00fcn i\u00e7inde %5-12 aras\u0131nda y\u00fckseltir. A\u011fustos 2025 raporu, %41 gelir art\u0131\u015f\u0131 ve y\u0131l\u0131n ikinci rehberlik art\u0131\u015f\u0131 nedeniyle \u00f6zellikle g\u00fc\u00e7l\u00fc bir tepki yaratt\u0131.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>Halozyme hisseleri y\u0131lba\u015f\u0131ndan bu yana ola\u011fan\u00fcst\u00fc bir <strong>%40,12 kazan\u00e7<\/strong> sa\u011flad\u0131 ve 2025'in biyoteknoloji sekt\u00f6r\u00fcndeki \u00f6ne \u00e7\u0131kan performanslar\u0131ndan biri oldu<a href=\"https:\/\/companiesmarketcap.com\/halozyme-therapeutics\/stock-price-history\/\">Companies Market Cap<\/a>.<\/p> <p><strong>\u015eubat<\/strong>: 52,30 $ (kazan\u00e7 sonras\u0131 momentum)<br\/> <strong>Mart<\/strong>: 58,90 $ (ortakl\u0131k geni\u015fleme haberi)<br\/> <strong>May\u0131s<\/strong>: 70,14 $ (1. \u00e7eyrek kazan\u00e7 a\u015f\u0131m\u0131 ve rehberlik art\u0131\u015f\u0131)<br\/> <strong>Temmuz<\/strong>: 71,80 $ (d\u00fczenleyici onaylar\u0131n etkisi)<br\/> <strong>A\u011fustos<\/strong>: 73,18 $ (2. \u00e7eyrek m\u00fcthi\u015f sonu\u00e7lar)<\/p> <p>Bu etkileyici y\u00fckseli\u015f birka\u00e7 \u00f6nemli fakt\u00f6r\u00fc yans\u0131t\u0131yor:<\/p> <ul> <li><strong>Telif geliri patlamas\u0131<\/strong>: Y\u0131ll\u0131k %65 b\u00fcy\u00fcme ile 206 milyon $<\/li> <li><strong>Birden fazla rehberlik art\u0131\u015f\u0131<\/strong>: Y\u00f6netim 2025 projeksiyonlar\u0131n\u0131 iki kez y\u00fckseltti<\/li> <li><strong>D\u00fczenleyici zaferler<\/strong>: ENHANZE destekli tedaviler i\u00e7in yeni onaylar<\/li> <li><strong>Ortakl\u0131k geni\u015flemesi<\/strong>: \u0130lk 10 ila\u00e7 \u015firketiyle i\u015f birli\u011fi<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak beklenenler:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 67-70 $ aral\u0131\u011f\u0131 (mevcut konsens\u00fcs zirvelerden hafif geri \u00e7ekilme \u00f6ng\u00f6r\u00fcyor)<a href=\"https:\/\/stockanalysis.com\/stocks\/halo\/forecast\/\">Stock Analysis<\/a><br\/> <strong>2026<\/strong>: 75-85 $ (telif b\u00fcy\u00fcmesinde h\u0131zlanma)<br\/> <strong>2028<\/strong>: 90-110 $ (yeni ortakl\u0131k katk\u0131lar\u0131)<br\/> <strong>2030<\/strong>: 120-150 $ (platform geni\u015flemesi ve pazar hakimiyeti)<\/p> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli b\u00fcy\u00fcme i\u00e7in <strong>AL<\/strong>, ancak daha iyi giri\u015f noktalar\u0131 i\u00e7in kazan\u00e7 sonras\u0131 geri \u00e7ekilmeleri beklemek mant\u0131kl\u0131 olabilir.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Patent Davas\u0131<\/strong>: Merck ile devam eden anla\u015fmazl\u0131k fikri m\u00fclkiyet haklar\u0131n\u0131 etkileyebilir<a href=\"https:\/\/www.ainvest.com\/news\/halozyme-q2-2025-unpacking-contradictions-patent-litigation-enhanze-impact-regulatory-challenges-2508\/\">AInvest<\/a><\/li> <li><strong>D\u00fczenleyici Belirsizlik<\/strong>: Medicare fiyatland\u0131rma rehberli\u011fi de\u011fi\u015fiklikleri zorluk yarat\u0131yor<\/li> <li><strong>Uygulama Riski<\/strong>: Yeni \u00fcr\u00fcn lansman zamanlamalar\u0131nda gecikmeler olabilir<\/li> <li><strong>De\u011ferleme Endi\u015feleri<\/strong>: Hisse senedi t\u00fcm zamanlar\u0131n en y\u00fcksek seviyelerine yak\u0131n i\u015flem g\u00f6r\u00fcyor, tam de\u011ferlenmi\u015f olabilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme<\/strong>: 2. \u00e7eyrekte %41 gelir art\u0131\u015f\u0131, %65 telif b\u00fcy\u00fcmesi<a href=\"https:\/\/www.prnewswire.com\/news-releases\/halozyme-raises-2025-financial-guidance-ranges-and-reports-strong-second-quarter-2025-results-302522420.html\">PR Newswire<\/a><\/li> <li><strong>Rehberlik Art\u0131\u015flar\u0131<\/strong>: 2025 projeksiyonlar\u0131nda ikinci art\u0131\u015f g\u00fcveni g\u00f6steriyor<\/li> <li><strong>Yeni Ortakl\u0131klar<\/strong>: Enflamasyon tedavileri i\u00e7in ilk 10 ila\u00e7 \u015firketi i\u015f birli\u011fi<\/li> <li><strong>Pazar Geni\u015flemesi<\/strong>: ENHANZE teknolojisi 100'den fazla k\u00fcresel pazara ula\u015f\u0131yor<\/li> <li><strong>G\u00fc\u00e7l\u00fc Nakit \u00dcretimi<\/strong>: 548 milyon $ nakit pozisyonu b\u00fcy\u00fcme giri\u015fimlerini destekliyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'si kadar ilk pozisyon d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: T\u00fcm\u00fcn\u00fc bir kerede almak yerine par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Daha iyi giri\u015fler i\u00e7in 70 $ alt\u0131 geri \u00e7ekilmeleri izleyin<\/li> <li><strong>\u00c7e\u015fitlendirin<\/strong>: HALO, daha geni\u015f bir sa\u011fl\u0131k\/biyoteknoloji tahsisi i\u00e7inde olmal\u0131<\/li> <\/ol> <p>Esprili bir yorum: \"HALO ticareti, onlar\u0131n ila\u00e7 teslimat teknolojisi gibidir - bazen subkutan getirilerin portf\u00f6y\u00fcn\u00fcze d\u00fczg\u00fcn emilmesi i\u00e7in sabra ihtiyac\u0131n\u0131z vard\u0131r!\"<\/p> <h2>\u2705 Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>HALO'yu detayl\u0131 ara\u015ft\u0131r\u0131n<\/td><td>\u0130\u015f modelini ve riskleri anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limit emri verin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td><td>Kazan\u00e7 tarihlerini ve sekt\u00f6r haberlerini d\u00fczenli izleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, HALO gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum 5 $ depozito<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - Tek belge KYC s\u00fcreci ile h\u0131zl\u0131 i\u015flem<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Karlar\u0131n\u0131za eri\u015fmek i\u00e7in birden fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - Yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Halozyme: ENHANZE Devrimi<\/h2> <p>Halozyme Therapeutics, \u00e7\u0131\u011f\u0131r a\u00e7an ENHANZE ila\u00e7 teslimat teknolojisiyle ila\u00e7 inovasyonunun \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin platformu, geleneksel olarak intraven\u00f6z inf\u00fczyon gerektiren ila\u00e7lar\u0131n subkutan uygulanmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131larak hasta konforunu art\u0131r\u0131yor ve sa\u011fl\u0131k maliyetlerini d\u00fc\u015f\u00fcr\u00fcyor.<\/p> <p>\u0130\u015f modeli son derece basit: Halozyme, Roche, Johnson & Johnson ve Sanofi gibi b\u00fcy\u00fck ila\u00e7 \u015firketleriyle ortakl\u0131k yaparak ENHANZE destekli tedavilerin her dozundan telif hakk\u0131 kazan\u0131yor. Bu, \u015fu anda sadece telif gelirlerinden \u00e7eyrek bazda 200 milyon dolar\u0131n \u00fczerinde y\u00fcksek marjl\u0131, \u00f6l\u00e7eklenebilir bir gelir ak\u0131\u015f\u0131 yarat\u0131yor.<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: Halozyme teknolojisi, 100'den fazla k\u00fcresel pazarda on ticarile\u015fmi\u015f \u00fcr\u00fcnle bir milyondan fazla hastan\u0131n hayat\u0131na dokundu - bu, Dallas, Teksas'\u0131n t\u00fcm n\u00fcfusuna yenilik\u00e7i tedavi sa\u011flamak gibi bir \u015fey!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve \u00d6nemli Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, Halozyme Therapeutics (HALO) NASDAQ borsas\u0131nda <strong>73,18 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Hisse senedi, 2025 boyunca ola\u011fan\u00fcst\u00fc bir g\u00fc\u00e7 g\u00f6stererek t\u00fcm zamanlar\u0131n en y\u00fcksek kapan\u0131\u015f fiyat\u0131na ula\u015ft\u0131<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/HALO\/halozyme-therapeutics\/stock-price-history\">Macrotrends<\/a>.<\/p>\n<p><strong>Takviminize not edin: 30 Ekim 2025<\/strong>, HALO yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in kesinlikle kritik bir tarih. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn. Tarihsel olarak, Halozyme&#8217;\u0131n kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 HALO Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Son tarihleri inceledi\u011fimizde kazan\u00e7lar etraf\u0131nda belirgin bir volatilite paterni g\u00f6r\u00fcl\u00fcyor:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7 A\u015f\u0131m\u0131<\/td>\n<td>68,50 $<\/td>\n<td><strong>%6,8 Art\u0131\u015f<\/strong> (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>6 May 2025<\/td>\n<td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>62,30 $<\/td>\n<td><strong>%12,7 Art\u0131\u015f<\/strong> (g\u00fc\u00e7l\u00fc rehberlik)<\/td>\n<\/tr>\n<tr>\n<td>25 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Rapor<\/td>\n<td>58,90 $<\/td>\n<td><strong>%5,2 Art\u0131\u015f<\/strong> (rekor gelir)<\/td>\n<\/tr>\n<tr>\n<td>5 Kas 2024<\/td>\n<td>Ortakl\u0131k Haberi<\/td>\n<td>54,20 $<\/td>\n<td><strong>%7,1 Art\u0131\u015f<\/strong> (yeni i\u015f birli\u011fi)<\/td>\n<\/tr>\n<tr>\n<td>8 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>51,80 $<\/td>\n<td><strong>%3,5 Azal\u0131\u015f<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>9 May 2024<\/td>\n<td>FDA Onay\u0131<\/td>\n<td>48,60 $<\/td>\n<td><strong>%9,8 Art\u0131\u015f<\/strong> (d\u00fczenleyici zafer)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri ve rehberlik art\u0131\u015flar\u0131 genellikle HALO&#8217;yu birka\u00e7 g\u00fcn i\u00e7inde %5-12 aras\u0131nda y\u00fckseltir. A\u011fustos 2025 raporu, %41 gelir art\u0131\u015f\u0131 ve y\u0131l\u0131n ikinci rehberlik art\u0131\u015f\u0131 nedeniyle \u00f6zellikle g\u00fc\u00e7l\u00fc bir tepki yaratt\u0131.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>Halozyme hisseleri y\u0131lba\u015f\u0131ndan bu yana ola\u011fan\u00fcst\u00fc bir <strong>%40,12 kazan\u00e7<\/strong> sa\u011flad\u0131 ve 2025&#8217;in biyoteknoloji sekt\u00f6r\u00fcndeki \u00f6ne \u00e7\u0131kan performanslar\u0131ndan biri oldu<a href=\"https:\/\/companiesmarketcap.com\/halozyme-therapeutics\/stock-price-history\/\">Companies Market Cap<\/a>.<\/p>\n<p><strong>\u015eubat<\/strong>: 52,30 $ (kazan\u00e7 sonras\u0131 momentum)<br \/> <strong>Mart<\/strong>: 58,90 $ (ortakl\u0131k geni\u015fleme haberi)<br \/> <strong>May\u0131s<\/strong>: 70,14 $ (1. \u00e7eyrek kazan\u00e7 a\u015f\u0131m\u0131 ve rehberlik art\u0131\u015f\u0131)<br \/> <strong>Temmuz<\/strong>: 71,80 $ (d\u00fczenleyici onaylar\u0131n etkisi)<br \/> <strong>A\u011fustos<\/strong>: 73,18 $ (2. \u00e7eyrek m\u00fcthi\u015f sonu\u00e7lar)<\/p>\n<p>Bu etkileyici y\u00fckseli\u015f birka\u00e7 \u00f6nemli fakt\u00f6r\u00fc yans\u0131t\u0131yor:<\/p>\n<ul>\n<li><strong>Telif geliri patlamas\u0131<\/strong>: Y\u0131ll\u0131k %65 b\u00fcy\u00fcme ile 206 milyon $<\/li>\n<li><strong>Birden fazla rehberlik art\u0131\u015f\u0131<\/strong>: Y\u00f6netim 2025 projeksiyonlar\u0131n\u0131 iki kez y\u00fckseltti<\/li>\n<li><strong>D\u00fczenleyici zaferler<\/strong>: ENHANZE destekli tedaviler i\u00e7in yeni onaylar<\/li>\n<li><strong>Ortakl\u0131k geni\u015flemesi<\/strong>: \u0130lk 10 ila\u00e7 \u015firketiyle i\u015f birli\u011fi<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak beklenenler:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 67-70 $ aral\u0131\u011f\u0131 (mevcut konsens\u00fcs zirvelerden hafif geri \u00e7ekilme \u00f6ng\u00f6r\u00fcyor)<a href=\"https:\/\/stockanalysis.com\/stocks\/halo\/forecast\/\">Stock Analysis<\/a><br \/> <strong>2026<\/strong>: 75-85 $ (telif b\u00fcy\u00fcmesinde h\u0131zlanma)<br \/> <strong>2028<\/strong>: 90-110 $ (yeni ortakl\u0131k katk\u0131lar\u0131)<br \/> <strong>2030<\/strong>: 120-150 $ (platform geni\u015flemesi ve pazar hakimiyeti)<\/p>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli b\u00fcy\u00fcme i\u00e7in <strong>AL<\/strong>, ancak daha iyi giri\u015f noktalar\u0131 i\u00e7in kazan\u00e7 sonras\u0131 geri \u00e7ekilmeleri beklemek mant\u0131kl\u0131 olabilir.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Patent Davas\u0131<\/strong>: Merck ile devam eden anla\u015fmazl\u0131k fikri m\u00fclkiyet haklar\u0131n\u0131 etkileyebilir<a href=\"https:\/\/www.ainvest.com\/news\/halozyme-q2-2025-unpacking-contradictions-patent-litigation-enhanze-impact-regulatory-challenges-2508\/\">AInvest<\/a><\/li>\n<li><strong>D\u00fczenleyici Belirsizlik<\/strong>: Medicare fiyatland\u0131rma rehberli\u011fi de\u011fi\u015fiklikleri zorluk yarat\u0131yor<\/li>\n<li><strong>Uygulama Riski<\/strong>: Yeni \u00fcr\u00fcn lansman zamanlamalar\u0131nda gecikmeler olabilir<\/li>\n<li><strong>De\u011ferleme Endi\u015feleri<\/strong>: Hisse senedi t\u00fcm zamanlar\u0131n en y\u00fcksek seviyelerine yak\u0131n i\u015flem g\u00f6r\u00fcyor, tam de\u011ferlenmi\u015f olabilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme<\/strong>: 2. \u00e7eyrekte %41 gelir art\u0131\u015f\u0131, %65 telif b\u00fcy\u00fcmesi<a href=\"https:\/\/www.prnewswire.com\/news-releases\/halozyme-raises-2025-financial-guidance-ranges-and-reports-strong-second-quarter-2025-results-302522420.html\">PR Newswire<\/a><\/li>\n<li><strong>Rehberlik Art\u0131\u015flar\u0131<\/strong>: 2025 projeksiyonlar\u0131nda ikinci art\u0131\u015f g\u00fcveni g\u00f6steriyor<\/li>\n<li><strong>Yeni Ortakl\u0131klar<\/strong>: Enflamasyon tedavileri i\u00e7in ilk 10 ila\u00e7 \u015firketi i\u015f birli\u011fi<\/li>\n<li><strong>Pazar Geni\u015flemesi<\/strong>: ENHANZE teknolojisi 100&#8217;den fazla k\u00fcresel pazara ula\u015f\u0131yor<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc Nakit \u00dcretimi<\/strong>: 548 milyon $ nakit pozisyonu b\u00fcy\u00fcme giri\u015fimlerini destekliyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;si kadar ilk pozisyon d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: T\u00fcm\u00fcn\u00fc bir kerede almak yerine par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Daha iyi giri\u015fler i\u00e7in 70 $ alt\u0131 geri \u00e7ekilmeleri izleyin<\/li>\n<li><strong>\u00c7e\u015fitlendirin<\/strong>: HALO, daha geni\u015f bir sa\u011fl\u0131k\/biyoteknoloji tahsisi i\u00e7inde olmal\u0131<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;HALO ticareti, onlar\u0131n ila\u00e7 teslimat teknolojisi gibidir &#8211; bazen subkutan getirilerin portf\u00f6y\u00fcn\u00fcze d\u00fczg\u00fcn emilmesi i\u00e7in sabra ihtiyac\u0131n\u0131z vard\u0131r!&#8221;<\/p>\n<h2>\u2705 Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>HALO&#8217;yu detayl\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>\u0130\u015f modelini ve riskleri anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit emri verin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td>\n<td>Kazan\u00e7 tarihlerini ve sekt\u00f6r haberlerini d\u00fczenli izleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, HALO gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum 5 $ depozito<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; Tek belge KYC s\u00fcreci ile h\u0131zl\u0131 i\u015flem<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Karlar\u0131n\u0131za eri\u015fmek i\u00e7in birden fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; Yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Halozyme: ENHANZE Devrimi<\/h2>\n<p>Halozyme Therapeutics, \u00e7\u0131\u011f\u0131r a\u00e7an ENHANZE ila\u00e7 teslimat teknolojisiyle ila\u00e7 inovasyonunun \u00f6n saflar\u0131nda yer al\u0131yor. \u015eirketin platformu, geleneksel olarak intraven\u00f6z inf\u00fczyon gerektiren ila\u00e7lar\u0131n subkutan uygulanmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131larak hasta konforunu art\u0131r\u0131yor ve sa\u011fl\u0131k maliyetlerini d\u00fc\u015f\u00fcr\u00fcyor.<\/p>\n<p>\u0130\u015f modeli son derece basit: Halozyme, Roche, Johnson &#038; Johnson ve Sanofi gibi b\u00fcy\u00fck ila\u00e7 \u015firketleriyle ortakl\u0131k yaparak ENHANZE destekli tedavilerin her dozundan telif hakk\u0131 kazan\u0131yor. Bu, \u015fu anda sadece telif gelirlerinden \u00e7eyrek bazda 200 milyon dolar\u0131n \u00fczerinde y\u00fcksek marjl\u0131, \u00f6l\u00e7eklenebilir bir gelir ak\u0131\u015f\u0131 yarat\u0131yor.<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: Halozyme teknolojisi, 100&#8217;den fazla k\u00fcresel pazarda on ticarile\u015fmi\u015f \u00fcr\u00fcnle bir milyondan fazla hastan\u0131n hayat\u0131na dokundu &#8211; bu, Dallas, Teksas&#8217;\u0131n t\u00fcm n\u00fcfusuna yenilik\u00e7i tedavi sa\u011flamak gibi bir \u015fey!<\/p>\n"},"faq":[{"question":"Halozyme Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Halozyme Therapeutics hisseleri NASDAQ borsas\u0131nda HALO sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"HALO hisseleri i\u00e7in en iyi yat\u0131r\u0131m stratejisi nedir?","answer":"Uzun vadeli b\u00fcy\u00fcme potansiyeli nedeniyle, k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yaparak ve kazan\u00e7 raporlar\u0131 sonras\u0131 olas\u0131 geri \u00e7ekilmeleri takip ederek yat\u0131r\u0131m yapmak \u00f6nerilir."},{"question":"Halozyme'nin ENHANZE teknolojisi nedir?","answer":"ENHANZE, ila\u00e7lar\u0131n subkutan (deri alt\u0131) uygulanmas\u0131n\u0131 sa\u011flayan yenilik\u00e7i bir ila\u00e7 teslimat teknolojisidir. Bu teknoloji, intraven\u00f6z inf\u00fczyon gerektiren ila\u00e7lar\u0131n daha kolay ve konforlu \u015fekilde uygulanmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131lar."},{"question":"Halozyme'nin 2025 finansal beklentileri nelerdir?","answer":"2025 y\u0131l\u0131 i\u00e7in \u015firket, g\u00fc\u00e7l\u00fc gelir ve telif b\u00fcy\u00fcmesi ile birlikte birka\u00e7 kez finansal rehberlik art\u0131\u015f\u0131 yapm\u0131\u015ft\u0131r. Y\u0131l sonunda hisse fiyat\u0131n\u0131n 67-70 $ aral\u0131\u011f\u0131nda olmas\u0131 beklenmektedir."},{"question":"Halozyme hisseleri i\u00e7in riskler nelerdir?","answer":"Patent davalar\u0131, d\u00fczenleyici belirsizlikler, \u00fcr\u00fcn lansman gecikmeleri ve hisse de\u011ferlemesinin y\u00fcksek olmas\u0131 temel riskler aras\u0131ndad\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Halozyme Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Halozyme Therapeutics hisseleri NASDAQ borsas\u0131nda HALO sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"HALO hisseleri i\u00e7in en iyi yat\u0131r\u0131m stratejisi nedir?","answer":"Uzun vadeli b\u00fcy\u00fcme potansiyeli nedeniyle, k\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yaparak ve kazan\u00e7 raporlar\u0131 sonras\u0131 olas\u0131 geri \u00e7ekilmeleri takip ederek yat\u0131r\u0131m yapmak \u00f6nerilir."},{"question":"Halozyme'nin ENHANZE teknolojisi nedir?","answer":"ENHANZE, ila\u00e7lar\u0131n subkutan (deri alt\u0131) uygulanmas\u0131n\u0131 sa\u011flayan yenilik\u00e7i bir ila\u00e7 teslimat teknolojisidir. Bu teknoloji, intraven\u00f6z inf\u00fczyon gerektiren ila\u00e7lar\u0131n daha kolay ve konforlu \u015fekilde uygulanmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131lar."},{"question":"Halozyme'nin 2025 finansal beklentileri nelerdir?","answer":"2025 y\u0131l\u0131 i\u00e7in \u015firket, g\u00fc\u00e7l\u00fc gelir ve telif b\u00fcy\u00fcmesi ile birlikte birka\u00e7 kez finansal rehberlik art\u0131\u015f\u0131 yapm\u0131\u015ft\u0131r. Y\u0131l sonunda hisse fiyat\u0131n\u0131n 67-70 $ aral\u0131\u011f\u0131nda olmas\u0131 beklenmektedir."},{"question":"Halozyme hisseleri i\u00e7in riskler nelerdir?","answer":"Patent davalar\u0131, d\u00fczenleyici belirsizlikler, \u00fcr\u00fcn lansman gecikmeleri ve hisse de\u011ferlemesinin y\u00fcksek olmas\u0131 temel riskler aras\u0131ndad\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:34:42+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T10:34:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\",\"name\":\"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-28T10:34:42+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:34:42+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T10:34:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/","name":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-28T10:34:42+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Halozyme Therapeutics, Inc. (HALO) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Halozyme Therapeutics, Inc. (HALO) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354007,"slug":"how-to-buy-halozyme-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Halozyme Therapeutics, Inc. (HALO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Halozyme Therapeutics, Inc. (HALO)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":353999,"slug":"how-to-buy-halozyme-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Halozyme Therapeutics, Inc. (HALO) - Investimento em a\u00e7\u00f5es da Halozyme Therapeutics, Inc. (HALO)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-halozyme-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354005"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}